Literature DB >> 8987871

Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells.

K Yoshioka1, M Saito, K B Oh, Y Nemoto, H Matsuoka, M Natsume, H Abe.   

Abstract

A fluorescent derivative of D-glucose, 2-NBDG, which was previously developed for the evaluation of glucose uptake activity by living cells, was used on Escherichia coli cells and its fate after incorporation in the cells was investigated. 2-NBDG was converted to another fluorescent derivative (2-NBDG metabolite) immediately after it was taken by E. coli cells. This 2-NBDG metabolite was then decomposed to non-fluorescent forms. 2-NBDG metabolite was decomposed into the original 2-NBDG by G6Pase with concurrent liberation of inorganic phosphate. Furthermore, FAB/MS analysis showed that its molecular weight was 420, the same value as that of 2-NBDG 6-phosphate. These indicate 2-NBDG metabolite should be 2-NBDG 6-phosphate. Based on these results, the feasibility of 2-NBDG as a fluorescent non-toxic probe for glucose uptake activity and its application to viability assessment of various living systems are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987871     DOI: 10.1271/bbb.60.1899

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  45 in total

1.  Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells.

Authors:  Wing Y Lam; Amy M Becker; Krista M Kennerly; Rachel Wong; Jonathan D Curtis; Elizabeth M Llufrio; Kyle S McCommis; Johannes Fahrmann; Hannah A Pizzato; Ryan M Nunley; Jieun Lee; Michael J Wolfgang; Gary J Patti; Brian N Finck; Erika L Pearce; Deepta Bhattacharya
Journal:  Immunity       Date:  2016-07-05       Impact factor: 31.745

Review 2.  MicroRNA regulation and analytical methods in cancer cell metabolism.

Authors:  Ling-Fei Zhang; Shuai Jiang; Mo-Fang Liu
Journal:  Cell Mol Life Sci       Date:  2017-03-20       Impact factor: 9.261

3.  A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells.

Authors:  Jelena Grahovac; Marijana Pavlović; Marija Ostojić
Journal:  Methods Mol Biol       Date:  2021

Review 4.  The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism.

Authors:  Benjamin L Cox; Thomas R Mackie; Kevin W Eliceiri
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

5.  Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Authors:  Nitin Nitin; Alicia L Carlson; Tim Muldoon; Adel K El-Naggar; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

6.  2-NBDG as a marker for detecting glucose uptake in reactive astrocytes exposed to oxygen-glucose deprivation in vitro.

Authors:  Yan Chen; Junjian Zhang; Xiang-Yang Zhang
Journal:  J Mol Neurosci       Date:  2014-08-06       Impact factor: 3.444

7.  Use of a Fluorescent Analog of Glucose (2-NBDG) To Identify Uncultured Rumen Bacteria That Take Up Glucose.

Authors:  Junyi Tao; Courtney McCourt; Halima Sultana; Corwin Nelson; John Driver; Timothy J Hackmann
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

8.  Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography.

Authors:  Rahul A Sheth; Lee Josephson; Umar Mahmood
Journal:  J Biomed Opt       Date:  2009 Nov-Dec       Impact factor: 3.170

9.  2-NBDG, a fluorescent analogue of glucose, as a marker for detecting cell electropermeabilization in vitro.

Authors:  Elham Raeisi; Lluis M Mir
Journal:  J Membr Biol       Date:  2012-08-11       Impact factor: 1.843

10.  Vital-dye-enhanced multimodal imaging of neoplastic progression in a mouse model of oral carcinogenesis.

Authors:  Anne Hellebust; Kelsey Rosbach; Jessica Keren Wu; Jennifer Nguyen; Ann Gillenwater; Nadarajah Vigneswaran; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2013-12       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.